首页> 外文期刊>Oral oncology >Toluidine blue uptake in potentially malignant oral lesions in vivo: clinical and histological assessment.
【24h】

Toluidine blue uptake in potentially malignant oral lesions in vivo: clinical and histological assessment.

机译:体内潜在的恶性口腔病变中甲苯胺蓝的摄取:临床和组织学评估。

获取原文
获取原文并翻译 | 示例
           

摘要

To assess the histological features of in vivo toluidine blue (TB) uptake in potentially malignant oral lesions (PML) and to determine whether any were related to clinical Dark versus Pale Royal Blue stain and/or to the malignant/dysplastic nature of the lesions. Frozen sections were used to evaluate TB extra- and intra-epithelial distribution, depth of penetration and nuclear or extra-nuclear uptake. Eighteen lesions were studied. The clinical appearance of a Dark Royal Blue stain was significantly related to the nuclear uptake of the dye. Conversely Pale Royal Blue staining was unrelated to any histological feature. Dark Royal Blue-malignant lesions had more nuclear uptake than benign lesions. The results suggest that Dark Royal Blue staining is the true positive outcome of a TB test and showed that Dark Royal Blue-malignant and Dark Royal Blue-benign lesions have a different histological pattern of uptake.
机译:评估潜在的恶性口腔病变(PML)中体内甲苯胺蓝(TB)摄取的组织学特征,并确定是否与临床深色或浅皇家蓝染色和/或病变的恶性/增生性质有关。冷冻切片用于评估结核上皮内和上皮内分布,穿透深度以及核或核外摄取。研究了十八个病变。深宝蓝色的临床表现与染料的核吸收显着相关。相反,淡皇家蓝染色与任何组织学特征无关。深皇家蓝恶性病变比良性病变具有更多的核摄取。结果表明,深皇家蓝染色是结核病检测的真正阳性结果,并表明深皇家蓝恶性和深皇家蓝良性病变具有不同的组织学摄取模式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号